[{"AccountsPayableCurrent_0_Q2_USD":21179000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":-97000.0,"MarketableSecuritiesCurrent_0_Q2_USD":231882000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":3208580.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":3437358.0,"IncrementalCommonSharesAttributableToContingentlyIssuableShares_1_Q2_shares":104092.0,"IncrementalCommonSharesAttributableToContingentlyIssuableShares_2_Q2_shares":96163.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":9686000.0,"IncrementalCommonSharesAttributableToConversionOfDebtSecurities_2_Q2_shares":9360853.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":102000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0_Q2_security":0.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_2_Q2_USD":0.0,"FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersNet_2_Q2_USD":0.0,"FinanceLeaseLiability_0_Q2_USD":1432000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":480000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q2_USD":1551000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":526000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":47149000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":213000.0,"IncrementalCommonSharesAttributableToConversionOfDebtSecurities_1_Q2_shares":14247835.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":13169000.0,"EarningsPerShareDiluted_1_Q2_USD":0.7,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":952000.0,"IncreaseDecreaseInAccountsPayableTrade_2_Q2_USD":-5132000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":12000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":12000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q2_shares":88660280.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":83775353.0,"NotesPayableRelatedPartiesNoncurrent_0_Q2_USD":26399000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":58724000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":225057000.0,"ProceedsFromSaleOfMachineryAndEquipment_2_Q2_USD":167000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-319000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":289000.0,"OtherLiabilitiesCurrent_0_Q2_USD":3626000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":2620000.0,"ConvertibleSubordinatedDebtNoncurrent_0_Q2_USD":222409000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":94904000.0,"EarningsPerShareDiluted_2_Q2_USD":1.2,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":527000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":119000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":10352000.0,"OperatingLeasePayments_1_Q2_USD":800000.0,"OperatingLeasePayments_2_Q2_USD":1600000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":10999000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.081,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":880000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":231864000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2437000.0,"ProceedsFromStockPlans_2_Q2_USD":2557000.0,"PurchaseObligationDueInNextTwelveMonths_0_Q2_USD":27485000.0,"PurchaseObligationDueInSecondYear_0_Q2_USD":8403000.0,"PurchaseObligationDueInThirdYear_0_Q2_USD":600000.0,"PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_0_Q2_USD":12711000.0,"ReceivablesNetCurrent_0_Q2_USD":172486000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q2_USD":0.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":440000.0,"PurchaseObligation_0_Q2_USD":49199000.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":285000.0,"OperatingLeaseLiability_0_Q2_USD":12789000.0,"NetIncomeLossAttributableToParentDiluted_1_Q2_USD":62485000.0,"FinanceLeaseRightOfUseAsset_0_Q2_USD":1447000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.058,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":7761000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":1275000.0,"InventoryNoncurrent_0_Q2_USD":53792000.0,"LeaseCost_1_Q2_USD":800000.0,"LeaseCost_2_Q2_USD":1600000.0,"NetIncomeLossAttributableToParentDiluted_2_Q2_USD":100539000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":15390000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":2888000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":3438000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":3293000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1646000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":2601000.0,"LongTermLoansPayable_0_Q2_USD":74059000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q2_USD":12000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":700000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":8105000.0,"InterestExpenseDebt_2_Q2_USD":5936000.0,"InterestExpenseDebt_1_Q2_USD":3454000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":4167000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":5528000.0,"ProfitLoss_1_Q2_USD":59031000.0,"ProfitLoss_2_Q2_USD":94603000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":10320000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-800395000.0,"StockholdersEquity_0_Q2_USD":213377000.0,"NetIncomeLoss_1_Q2_USD":59031000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":71099773.0,"AccruedLiabilitiesCurrent_0_Q2_USD":25560000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"ConvertibleLongTermNotesPayable_0_Q2_USD":79198000.0,"DepreciationAndAmortization_2_Q2_USD":1355000.0,"DepreciationAndAmortization_1_Q2_USD":700000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.21,"InterestExpense_1_Q2_USD":5408000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":70880979.0,"InterestExpense_2_Q2_USD":9839000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":73668000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":214345000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-257000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":12748634.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":11384913.0,"Assets_0_Q2_USD":756611000.0,"AssetsCurrent_0_Q2_USD":675860000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":224617000.0,"CommonStockValue_0_Q2_USD":7000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-240864000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":60325000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":1294000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":2227000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":947000.0,"InventoryNet_0_Q2_USD":27192000.0,"Liabilities_0_Q2_USD":543234000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":756611000.0,"LiabilitiesCurrent_0_Q2_USD":129763000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":96830000.0,"OperatingExpenses_1_Q2_USD":70364000.0,"OperatingExpenses_2_Q2_USD":145676000.0,"OperatingIncomeLoss_1_Q2_USD":65310000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":423000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":491000.0,"EarningsPerShareBasic_1_Q2_USD":0.83,"EarningsPerShareBasic_2_Q2_USD":1.33,"Goodwill_0_Q2_USD":943000.0,"OtherAssetsNoncurrent_0_Q2_USD":1637000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2_Q2_USD":1528000.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":1523000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":71099773.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":15234000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1014022000.0,"FinancingReceivableAllowanceForCreditLosses_0_Q2_USD":0.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":135674000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":251854000.0,"InterestExpenseRelatedParty_1_Q2_USD":622000.0,"InterestExpenseRelatedParty_2_Q2_USD":1242000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":70880979.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":27776000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":3425000.0,"InventoryWorkInProcess_0_Q2_USD":64651000.0,"OperatingIncomeLoss_2_Q2_USD":106178000.0,"ProceedsFromConvertibleDebt_2_Q2_USD":222830000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":26173000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":59280000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":34052000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":69402000.0,"ShareBasedCompensation_2_Q2_USD":18980000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":3305000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":88660280.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":83775353.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":17456000.0,"IncreaseDecreaseInInventories_2_Q2_USD":25236000.0,"IncreaseDecreaseInPrepaidExpense_2_Q2_USD":5577000.0,"IncreaseDecreaseInReceivables_2_Q2_USD":30677000.0,"InventoryFinishedGoods_0_Q2_USD":11002000.0,"InventoryGross_0_Q2_USD":80984000.0,"InventoryRawMaterials_0_Q2_USD":5331000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":1388000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":2557000.0,"Ticker":"CHRS","CIK":"1512762","name":"COHERUS BIOSCIENCES, INC.","OfficialName":"Coherus BioSciences Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"802681020.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]